- Home
- KALA
KALA
KALA BIO Inc.
as 03-25-2025 12:34pm EST
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | N/A | IPO Year: | 2017 |
| Target Price: | $15.00 | AVG Volume (30 days): | 19.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -11.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.21 - $11.20 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of KALA BIO Inc. (KALA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Iwicki Mark T | KALA | CHIEF EXECUTIVE OFFICER | Jan 6 '25 | Sell | $7.63 | 5,779 | $44,093.77 | 280,076 | |
| Kharabi Darius | KALA | CHIEF BUSINESS OFFICER | Jan 6 '25 | Sell | $7.63 | 2,021 | $15,420.23 | 67,807 | |
| Brazzell Romulus K | KALA | SEE REMARKS | Jan 6 '25 | Sell | $7.63 | 2,446 | $18,662.98 | 92,418 | |
| Reumuth Mary | KALA | CHIEF FINANCIAL OFFICER | Jan 6 '25 | Sell | $7.63 | 1,706 | $13,016.78 | 68,581 | |
| BAKER BROS. ADVISORS LP | KALA | 10% Owner | Dec 30 '24 | Buy | $6.44 | 310,559 | $1,999,999.96 | 118,496 |
Latest KALA BIO Inc. News
KALA Breaking Stock News: Dive into KALA Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
GlobeNewswire
a month ago
KALA BIO Announces Chief Executive Officer Transition
GlobeNewswire
3 months ago
KALA BIO Announces $10,750,000 Private Placement
GlobeNewswire
4 months ago
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
GlobeNewswire
4 months ago
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
8 months ago
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
GlobeNewswire
8 months ago
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
9 months ago
KALA BIO Announces $12,500,000 Private Placement
Compare KALA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KALA KALA BIO Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.